trial

Cognitive Strategies in Early Psychosis 1

NCTId NCT07231497
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 3 · Recruiting
Enrollment 103 (estimated)
Sponsored by University of Minnesota
Primary completion 2030-04-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 3
Status
Recruiting
Enrollment
103 (estimated)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2025-10-31
Primary completion
2030-04-30
Eligibility
ALL · 18 Years · 35 Years

Interventions & indications

Drugs
modafinil

Sponsors

University of MinnesotaLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

2
Sophia Vinogradov, MDPrincipal Investigator
Caroline Cellard, Ph.DPrincipal Investigator

Sites

1 total
Minneapolis, United States

Linked catalysts

1
Cognitive Strategies in Early Psychosis 1 — primary completion2030-04-30

Facts & assertions

4 sourced
Enrollment
103
Phase
PHASE3
Primary Completion Date
2030-04-30
Status
RECRUITING
relationships
The graph out of here
drug
modafinil
drug
lead_sponsor
University of Minnesota
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Cognition
indication
Healthy Participants
indication
Psychotic Disorders
indication
investigator
Sophia Vinogradov, MD
person
Caroline Cellard, Ph.D
person